BIOMAT Database Logo BIOMAT Database Logo

Renal haemodynamics during propranolol treatment in patients with arterial hypertension and chronic renal failure. 1986

B A Jacobsen, and P Fjeldborg

The effect of propranolol on renal haemodynamics was studied in nine patients with arterial hypertension and moderate to severe chronic renal failure. A reduction of the renal function in this type of patient might have clinical consequence. The patients, whose glomerular filtration rate (GFR) ranged between 17 ml/min/1.73 m2 and 71 ml/min/1.73 m2, were studied during three 4-week periods with alternately placebo, propranolol (40 mg b.i.d.) and placebo treatment. The GFR and the effective renal plasma flow (ERPF) were determined as the plasma clearance of 51Cr-EDTA and 125I-hippurane. The GFR fell on the average 7% (95% confidence limits: 1-12%) during propranolol treatment, and the fall was reversible. No changes were found in ERPF. In conclusion, propranolol treatment in this type of patient causes a modest and reversible fall of GFR.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D012079 Renal Circulation The circulation of the BLOOD through the vessels of the KIDNEY. Kidney Circulation,Renal Blood Flow,Circulation, Kidney,Circulation, Renal,Blood Flow, Renal,Flow, Renal Blood
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B A Jacobsen, and P Fjeldborg
Renal haemodynamics after chronic treatment with labetalol and propranolol.
June 1982, British journal of clinical pharmacology,
B A Jacobsen, and P Fjeldborg
Systemic and renal haemodynamics during antihypertensive treatment with propranolol.
November 1973, Bruxelles medical,
B A Jacobsen, and P Fjeldborg
Abnormal renal haemodynamics during exercise in young patients with mild essential hypertension without treatment and during long-term propranolol therapy.
October 1978, Scandinavian journal of clinical and laboratory investigation,
B A Jacobsen, and P Fjeldborg
Changes in general haemodynamics and renal function during exercise in patients with arterial hypertension.
January 1975, Cor et vasa,
B A Jacobsen, and P Fjeldborg
Systemic haemodynamics, renal and platelet function during chronic propranolol administration in patients with compensated cirrhosis.
April 1987, Liver,
B A Jacobsen, and P Fjeldborg
[Propranolol in the control of arterial hypertension in patients with chronic renal insufficiency].
April 1975, Revista clinica espanola,
B A Jacobsen, and P Fjeldborg
[Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
January 1984, Terapevticheskii arkhiv,
B A Jacobsen, and P Fjeldborg
Slow-release nifedipine for treatment of arterial hypertension in patients with chronic renal failure.
January 1984, Contributions to nephrology,
B A Jacobsen, and P Fjeldborg
Effects of ACE inhibition on renal haemodynamics in essential hypertension and hypertension associated with chronic renal failure.
January 1991, Drugs,
B A Jacobsen, and P Fjeldborg
Treatment of hypertension in patients with chronic renal failure.
January 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Copied contents to your clipboard!